Barren pipelines abound – the drug drought of pharma.
Schering‘s promising clot drug continues to do well in trials.
Amgen and Roche go another round in court over anemia drugs – this round to Amgen.
Sleep drugs – wildly popular, but how effective? Related news: Sepracor‘s earnings (and a 16% cut in the sales force).
The 2007 drug company layoff tally – sobering.
Takeda‘s experimental cholesterol drug (lapaquistat) takes a hit.
Gila monster saliva diabetes drug looking good in longer-lasting version (Amylin‘s Byetta)
OK, it’s not pharma, but it’s a very cool idea for treating skin cancer – portable, inexpensive light therapy. Fascinating.
Roche Victim says
The pharmaceutical industry is totally cut throat. I am a recent victim of the layoffs at Roche Canada. The senior management, so called leaders, couldn’t manage their way out of a paper bag. They have inexperienced people in senior positions who have absolutely no idea what they are doing. Forecasting and budgeting – the haven’t a clue. My question, why don’t the executives (Ronnie Miller & his team of VP Losers) who make the decisions pay the price when there are job loses, instead of the “little folk” who just do their job and do what they are told. Of course there is no problem spending $300K on physician advisory boards. What a hypocritcal bunch. May they all rot in hell for what they have done to many families.